| Issue Date | Title | Author(s) |
| 2020 | Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation | Chen, Dongtai; Yan, Yan; Xie, Jingdun; Pan, Jiahao; Chen, Yonghua; Li, Qiang; Yuan, Yunfei; Zeng, Weian; Xing, Wei |
| 21-Jan-2022 | Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma | Yan, Yan; He, Wen; Chen, Yonghua; Li, Qiang; Pan, Jiahao; Yuan, Yunfei; Zeng, Weian; Chen, Dongtai; Xing, Wei |
| 2015 | Concise Construction of the Tricyclic Core of Bullataketals Enabled by a Biomimetic Intermolecular (3+3) Type Cycloaddition | Tan, Haibo; Liu, Hongxin; Chen, Xinzheng; Yuan, Yunfei; Chen, Kai; Qiu, Shengxiang |
| 2-Dec-2022 | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth | Yan, Yan; Chen, Yonghua; Pan, Jiahao; Xing, Wei; Li, Qiang; Wang, Yan; Gei, Liba; Yuan, Yunfei; Xie, Jingdun; Zeng, Weian; Chen, Dongtai |
| 2019 | The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma | Bai, Xue; Liu, Zhenzhen; Shao, Xiaojian; Wang, Di; Dong, Encheng; Wang, Yan; Wu, Chung-I; Yuan, Yunfei; Lu, Xuemei; Li, Chunyan |
| Dec-2020 | Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma | Yan, Yan; Pan, Jiahao; Chen, Yonghua; Xing, Wei; Li, Qiang; Wang, Dongyin; Zhou, Xiaoshuang; Xie, Jingdun; Miao, Changhong; Yuan, Yunfei; Zeng, Weian; Chen, Dongtai |
| 5-Apr-2022 | The nociceptin receptor promotes autophagy through NF-kB signaling and is transcriptionally regulated by E2F1 in HCC | Zhou, Xiaoshuang; Chen, Dongtai; Yan, Yan; Li, Qiang; Xing, Wei; Liu, Yanling; Chen, Yonghua; Wang, Dongyin; Yuan, Yunfei; Xie, Jingdun; Zeng, Weian; Pan, Jiahao |
| Sep-2021 | A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis | Wang, Yun; Chen, Xiuxing; Lin, Haocheng; Sun, Xiaoqiang; Fong, William Pat; Wu, Xiaojun; Pan, Zhizhong; Yuan, Yunfei; Liang, Jieying; Wang, Deshen; Du, Ziming; Xing, Baocai; Li, Yuhong |
| 2016 | Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study | Ye, Sheng-Long; Chen, Xiaoping; Yang, Jiamei; Bie, Ping; Zhang, Shuijun; Liu, Fengyong; Liu, Luming; Zhou, Jie; Dou, Kefeng; Hao, Chunyi; Shao, Guoliang; Xia, Qiang; Chen, Yajin; Yang, Jijin; Deng, Xiaxing; Liu, Yunpeng; Yuan, Yunfei; Fu, Zhiren; Nakajima, Keiko; Yip, Christina S. M.; Lu, Zhengguang |
| 2018 | Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study | Ye, Sheng-Long; Yang, Jiamei; Bie, Ping; Zhang, Shuijun; Chen, Xiaoping; Liu, Fengyong; Liu, Luming; Zhou, Jie; Dou, Kefeng; Hao, Chunyi; Shao, Guoliang; Xia, Qiang; Chen, Yajin; Yang, Jijin; Deng, Xiaxing; Liu, Yunpeng; Yuan, Yunfei; Fu, Zhiren; Nakajima, Keiko; Lv, Zhengguang |
